Finally, recognizing the limits of the analysis, given the small sample sizes, NfL, t-tau, p-tau, and Aβ42 levels did not significantly differ between bvFTD, PPA, and tauopathies (CBS + PSP). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.